LICENSING OPPORTUNITIES
Licensing Opportunities
The La Jolla Institute for Immunology is a world-renowned research organization specializing in human immunology and its role in human disease. Our 20+ principal investigators conduct groundbreaking, world changing research in all areas of immunology including oncology, cardiovascular disease, infectious diseases, allergy, inflammation, and autoimmunity. A number of their pioneering innovations are in clinical development. In addition, LJI is a leader in the worldwide effort for identification and bioinformatic characterization of antigens, including management of the Immune Epitope Database and the development of peptide pools used to diagnose viral infections and characterize immune response.
LJI and its researchers partner with companies in a variety of capacities, including as scientific advisors, through sponsored research collaborations and by licensing technologies. There are over 300 technologies available for licensing, some of which are listed below. LJI welcomes inquiries regarding licensing and other collaborative opportunities. Please contact us at bd@lji.org to get in touch with our business development group. We look forward to making introductions to investigators and exploring how we can work together.
Available Technologies
Infectious Disease
3-mer
A Novel Cytomegalovirus Cell-Entry Protein Complex
LCMV
A Novel Cytomegalovirus Cell-Entry Protein Complex
Rabies Virus
Stabilized, Trimeric Rabies Virus Glycoprotein
Tonsilitis and killer Tfh cells
Tonsillitis and Killer TFH Cells
Pan-flavivirus vaccine
Pan-Flavivirus Vaccine that Protects Against Zika Virus and Dengue Virus
Vaccine Design
Cancer
BATF/IRF4/NFKbid CAR T cells
BATF and IRF4 Cooperate to Counter Exhaustion in Tumor-Infiltrating CAR-T Cells
HVEM muteins
HVEM Muteins for Cancer and Other Uses
Monocyte modulation and control of tumor metastasis
Patrolling Monocytes Control Tumor Metastasis to the Lung
Rel-B-depleted CAR T cells
Rel-B-Depleted CAR T Cells
Novel Epitopes and Antigens
B. pertussis epitopes
Bordetella pertussis T Cell Epitopes and Megapools
Monkeypox epitopes
Monkeypox T Cell Epitopes and Megapools
Cockroach antigens/epitopes
Novel Cockroach Antigens and T Cell Epitopes
Mycobacterium tuberculosis antigens/epitopes
Antigens and Epitopes Derived from Mycobacterium tuberculosis
Dengue virus polypeptide sequences and epitopes
Dengue Virus Polypeptide Sequences and T Cell Epitopes
ApoB100 epitopes
Peptides for Preventing and Treating Atherosclerosis
Timothy grass allergens
Timothy Grass Antigens and T CellEpitopes
Allergy, Inflammation, and Autoimmune Diseases
COVID
VFLIP
SARS-CoV-2 Spike Glycoprotein with Improved Expression and Stability
Pan-VFLIP
NFKbid Overexpression Supports the Expansion and Survival of CD8+ Tumor-Infiltrating Lymphocytes
N antibodies
Anti-SARS-CoV-2 Nucleoprotein Antibodies
S antibodies
Anti-SARS-CoV-2 Spike Antibodies
Related News
- Research News